14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
AQB vs FRSX: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, AquaBounty Technologies, Inc. (AQB) captures the overall head-to-head institutional edge over Foresight Autonomous Holdings Ltd. (FRSX) on higher Unified Composite conviction (44.6/100 HOLD vs. 40.4/100 SELL) after splitting the core matrix 4–2 (led by Profitability & Quality, Balance Sheet & Cash Flow), while FRSX wins 3–2 across the 6-pillar growth and valuation breakdown. AQB trades at $0.82 (N/M Forward P/E, 0.0% operating margin) versus FRSX at $0.47 (N/M Forward P/E, -2642.2% operating margin).
Growth vs. Quality Trade-Off: AQB earns the overall head-to-head edge with a stronger Unified Composite Score (44.6/100 HOLD vs. FRSX 40.4/100 SELL) and 0.93β · 117% Vol risk profile, whereas FRSX leads top-line expansion (-32.8% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: AQB is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9); meanwhile FRSX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 17.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AQB vs FRSX. Trailing 12-month operating profitability (AQB 0.0% vs FRSX -2642.2%) and valuation multiples (AQB N/M vs FRSX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Auto Parts value chain with $2.0M market capitalization and -2642.2% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ AQB vs FRSX Key Questions & Quantitative Answers
As of Nov 17, 2026, AquaBounty Technologies, Inc. (AQB) captures the overall head-to-head institutional edge over Foresight Autonomous Holdings Ltd. (FRSX) on higher Unified Composite conviction (44.6/100 HOLD vs. 40.4/100 SELL) after splitting the core matrix 4–2 (led by Profitability & Quality, Balance Sheet & Cash Flow), while FRSX wins 3–2 across the 6-pillar growth and valuation breakdown. AQB trades at $0.82 (N/M Forward P/E, 0.0% operating margin) versus FRSX at $0.47 (N/M Forward P/E, -2642.2% operating margin). Growth vs. Quality Trade-Off: AQB earns the overall head-to-head edge with a stronger Unified Composite Score (44.6/100 HOLD vs. FRSX 40.4/100 SELL) and 0.93β · 117% Vol risk profile, whereas FRSX leads top-line expansion (-32.8% YoY revenue growth, N/M PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: AQB is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.9); meanwhile FRSX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 17.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
FRSX leads the Growth & Scale pillar: AQB posts -93.5% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with FRSX at -32.8% YoY revenue growth and +0.0% YoY earnings growth on $445,000 TTM revenue (65.4% gross margin, -2642.2% operating margin). On trailing 12-month operating scale, AQB generates N/A in USD-normalized revenue versus $445,000 for FRSX. In operating R&D and SG&A reinvestment, AQB deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for FRSX.
FRSX screens cheaper on headline valuation multiples. AQB trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin), whereas FRSX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 4.5x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AQB (-68.9% ROE) versus FRSX (-205.9% ROE) capital efficiency.
In options market volatility and institutional positioning, AQB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (0.93β · 117% Vol realized risk). By comparison, FRSX carries N/A implied volatility (N/A, Unclassified), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.23β · 57% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.